Sioux Falls is rolling out the welcome mat for a new business relocating from Irvine, California.

NanoBlood LLC is relocating to the South Dakota Technology Business Center (SDTBC) in Sioux Falls, to continue the regulatory and commercial development of its nano red blood cell as a life-saving drug in critical care and transfusion medicine.

Governor Dennis Daugaard says this is a win for Sioux Falls and South Dakota.

This is the kind of science that rewrites medical history, it’s the kind of novel drug that saves lives and it is happening right here in South Dakota. It is my pleasure to support the translation of nano red blood cell from bench-to-bedside for unmet domestic and global medical needs.

The Governor’s Office of Economic Development has funded NanoBlood through two Proof of Concept projects. NanoBlood is targeting FDA fast track and breakthrough designation to bring this drug to patients in need and plans to build a commercial manufacturing plant in Sioux Falls at the USD Research Park and will work jointly on certain projects with the USD Graduate Education and Applied Research Center.

Nanoblood’s medical technology could mean an injection could replace blood transfusions for patients with in sickle cell issues and stroke patients.

Carlton Hsia chairman and CEO of NanoBlood looks to the future optimism.

I am very grateful and appreciative of Gov. Daugaard’s support of commercial development of nano red blood cell in South Dakota for domestic and global need in critical care and transfusion medicine.

 

 

For more information about NanoBlood LLC visit www.nanorbc.com